Intraoperative treatment planning for radioactive seed implant therapy for prostate cancer

I D Kaplan; E J Holupka; P Meskell; S J Soon; B Saltzman; P Church; G P Kearney

doi:10.1016/s0090-4295(00)00616-6

Intraoperative treatment planning for radioactive seed implant therapy for prostate cancer

Urology. 2000 Sep 1;56(3):492-5. doi: 10.1016/s0090-4295(00)00616-6.

Authors

I D Kaplan¹, E J Holupka, P Meskell, S J Soon, B Saltzman, P Church, G P Kearney

Affiliation

¹ Joint Center for Radiation Therapy, Harvard Medical School, Boston, Massachusetts 02115, USA.

PMID: 10962322
DOI: 10.1016/s0090-4295(00)00616-6

Abstract

We describe a procedure for intraoperative treatment planning for seed implantation. One hundred seven treatment plans have been analyzed at the Beth Israel Deaconess Medical Center and affiliated hospitals. The average time for the intraoperative procedure was 1. 74 hours. No significant difference in dose coverage to the prostate or normal tissues was evident.

Publication types

Multicenter Study

MeSH terms

Brachytherapy / methods*
Humans
Intraoperative Period
Iodine Radioisotopes / therapeutic use*
Male
Operating Rooms
Prostatic Neoplasms / radiotherapy*
Prostatic Neoplasms / surgery
Radiotherapy Dosage

Substances

Iodine Radioisotopes